Disease modifying treatments for Parkinson’s disease – an update by Vijay Chandran, Donald G Grosset

Get full text

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis” by Michael Lawton, Yoav Ben-Shlomo, Dilan Athauda, Dilan Athauda, Naveed Malek, Donald G. Grosset

Get full text

Comparison between four published definitions of hyposmia in Parkinson's disease by Sofia Kanavou, Vanessa Pitz, Michael A. Lawton, Naveed Malek, Katherine A. Grosset, Huw R. Morris, Yoav Ben‐Shlomo, Donald G. Grosset

Get full text

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features by Jonathan P. Bestwick, Stephen D. Auger, Anette E. Schrag, Donald G. Grosset, Sofia Kanavou, Gavin Giovannoni, Andrew J. Lees, Jack Cuzick, Alastair J. Noyce

Get full text

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation by Cynthia Sandor, Stephanie Millin, Andrew Dahl, Ann-Kathrin Schalkamp, Michael Lawton, Leon Hubbard, Nabila Rahman, Nigel Williams, Yoav Ben-Shlomo, Donald G. Grosset, Michele T. Hu, Jonathan Marchini, Caleb Webber

Get full text

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease by Alejandro Martinez-Carrasco, Raquel Real, Michael Lawton, Hirotaka Iwaki, Manuela M. X. Tan, Lesley Wu, Nigel M. Williams, Camille Carroll, Michele T. M. Hu, Donald G. Grosset, John Hardy, Mina Ryten, Tom Foltynie, Yoav Ben-Shlomo, Maryam Shoai, Huw R. Morris

Get full text